相关实验视频

Updated: Jun 3, 2025

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

在牛皮关节炎中使用分子向药物的精密医学

Ippei Miyagawa¹, Yoshiya Tanaka²

¹The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan.

Therapeutic advances in musculoskeletal disease

|January 8, 2025

概括

牛皮关节炎 (PsA) 治疗由于其异质性而复杂. 精准医学,使用基于患者生物标志物的向药物,有望改善PsA患者的治疗反应.

科学领域:

类风湿病学类风湿病学
免疫学免疫学免疫学
药理学药理学是指药理学的学科.

背景情况:

牛皮关节炎 (PsA) 呈现出各种临床特征,包括皮肤,关节和全身的表现.
肺炎患者面临与生活方式相关的疾病和心血管事件的风险增加.
目前针对PsA的分子向疗法包括抗TNF-α,IL-17,IL-23,CTLA-4,JAK和PDE4的药物.

研究的目的:

为了解决PsA的临床和分子异质性.
探索精准医学的潜力,以改善PsA的治疗结果.
评估涉及分子向药物的治疗策略,根据患者生物标志物分层分层.

主要方法:

使用外周血液淋巴细胞表型和血清细胞因子度来对PsA患者进行分层.
启动一项随机对照试验,以测试这种精准医学策略的有效性.
基于生物标志物概况的治疗反应分析.

主要成果:

初步报告表明,基于患者分层的分子向药物的战略使用可能会增强治疗反应.
一项随机对照试验正在进行中,以证实这些发现.
这项研究旨在验证生物标志物指导的治疗选择的有效性.

结论:

PsA管理需要同时改善多种症状,这通常是当前有限的选择所带来的挑战.
以生物标志物为指导的精准医学有可能优化PsA治疗.
进一步的数据和转向基于生物标志物的临床试验对于在PsA中可行的精准医学至关重要.

关键词:

精准医学是一门精准医学.牛皮关节炎牛皮关节炎治疗治疗治疗治疗治疗治疗

更多相关视频

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...